Data catalog

ClinicalTrials.gov studies

About 571K records

More records

Continuing the ClinicalTrials.gov studies list, 1000 records per page, after NCT00004852.

  1. NCT00004853Comparison of Filgrastim and Filgrastim SD/01in Boosting White Cell Counts After Intensive…
  2. NCT00004854The Safety and Efficacy of Adjunct Carvedilol in Children With Moderate Heart Failure
  3. NCT00004855Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients…
  4. NCT00004856Trastuzumab in Treating Patients With Previously Treated, Locally Advanced, or Metastatic…
  5. NCT00004857Fludarabine Followed by Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia
  6. NCT00004858Monoclonal Antibody Therapy in Treating Patients With Recurrent Acute Lymphoblastic…
  7. NCT00004859Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients…
  8. NCT00004860Fluorouracil-Uracil and Leucovorin in Treating Elderly Patients With Metastatic Colorectal…
  9. NCT00004861Gemcitabine With or Without CI-994 in Treating Patients With Advanced Pancreatic Cancer
  10. NCT00004862Augmerosen Plus Fludarabine and Cytarabine in Treating Patients With Refractory or…
  11. NCT00004863Paclitaxel and GEM 231 in Treating Patients With Recurrent or Refractory Solid Tumors
  12. NCT00004864Docetaxel and GEM 231 in Treating Patients With Recurrent or Refractory Solid Tumors
  13. NCT00004865Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the…
  14. NCT00004866DX-8951f in Treating Women Who Have Advanced or Recurrent Cancer of the Cervix
  15. NCT00004867Positron Emission Tomography in Determining Stage of Esophageal Cancer
  16. NCT00004868SU5416 in Treating Patients With Recurrent Astrocytoma or Mixed Glioma That Has Not…
  17. NCT00004870Olimersen and Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal…
  18. NCT00004871Azacitidine Plus Phenylbutyrate in Treating Patients With Acute Myeloid Leukemia or…
  19. NCT00004872Endostatin in Treating Patients With Advanced Refractory Solid Tumors
  20. NCT00004873Combination Chemotherapy in Treating Patients With Advanced Stomach Cancer
  21. NCT00004874Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma
  22. NCT00004875Heparin or Enoxaparin in Patients With Cancer
  23. NCT00004876Carboplatin With or Without Thalidomide in Treating Patients With Ovarian Epithelial…
  24. NCT00004877BMS-214662 in Treating Patients With Advanced Solid Tumors
  25. NCT00004878Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid…
  26. NCT00004879Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate…
  27. NCT00004880Vaccine Therapy in Treating Patients With Advanced Kidney Cancer
  28. NCT00004881Vaccine Therapy in Treating Patients With Advanced Cancer
  29. NCT00004883Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer…
  30. NCT00004884Docetaxel and Gemcitabine Compared With Docetaxel and Cisplatin in Treating Patients With…
  31. NCT00004885Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients With…
  32. NCT00004886MS 209 Plus Docetaxel in Treating Patients With Advanced Solid Tumors
  33. NCT00004887Paclitaxel and Carboplatin Chemotherapy Compared With Standard Chemotherapy in Treating…
  34. NCT00004888Combination Chemotherapy With or Without Trastuzumab in Treating Women With Metastatic…
  35. NCT00004889Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia
  36. NCT00004890Biomed 101 and Interleukin-2 in Treating Patients With Kidney Cancer
  37. NCT00004891PET and CT Scans in Patients With Locally Advanced Primary Rectal Cancer That Can Be…
  38. NCT00004892O6-Benzylguanine and Carmustine Implants in Treating Patients With Recurrent Malignant…
  39. NCT00004893Interleukin-12 in Treating Patients With Metastatic or Recurrent Breast Cancer
  40. NCT00004895Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be…
  41. NCT00004896Busulfan and Cyclophosphamide Followed by Bone Marrow Transplantation in Treating Patients…
  42. NCT00004897Combination Chemotherapy and Interferon Alfa Followed by Surgery and/or Radiation Therapy…
  43. NCT00004898Radiation Therapy and Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating…
  44. NCT00004899Chemotherapy Plus Bone Marrow Transplantation and Filgrastim in Treating Patients With…
  45. NCT00004900Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Metastatic…
  46. NCT00004901Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Mouth…
  47. NCT00004902Tocladesine in Treating Patients With Recurrent or Refractory Multiple Myeloma
  48. NCT00004903Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients…
  49. NCT00004904Stem Cell Transplantation in Treating Patients With Hematologic Cancer
  50. NCT00004905Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients…
  51. NCT00004906Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With…
  52. NCT00004907Chemotherapy and Radiation Therapy Plus Bone Marrow or Peripheral Stem Cell…
  53. NCT00004908Radiation Therapy and Cyclophosphamide Plus Peripheral Stem Cell Transplantation in…
  54. NCT00004909Effect of Chemotherapy Given Either by Mouth or by Infusion on the Quality of Life of…
  55. NCT00004910Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal…
  56. NCT00004911Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction
  57. NCT00004912Megestrol and Exercise in Treating Patients With Cancer-Related Weight Loss
  58. NCT00004913Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
  59. NCT00004914Exercise Plus Epoetin Alfa in Treating Cancer Patients Who Have Anemia-Related Fatigue
  60. NCT00004915Raloxifene in Treating Patients With Persistent or Recurrent Endometrial Cancer
  61. NCT00004916Ifosfamide, Teniposide, and Paclitaxel in Treating Patients With Relapsed Non-Hodgkin's…
  62. NCT00004917Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and…
  63. NCT00004918Vaccine Therapy Plus Immune Adjuvant in Treating Patients With Chronic Myeloid Leukemia…
  64. NCT00004919Irinotecan and Cisplatin With or Without Amifostine in Treating Children With Solid Tumors…
  65. NCT00004920Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of…
  66. NCT00004921High-Dose Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage…
  67. NCT00004922Irinotecan in Treating Patients With Advanced Neuroendocrine Tumors
  68. NCT00004923Docetaxel and Irinotecan in Treating Patients With Advanced Solid Tumors
  69. NCT00004924Paclitaxel and Irinotecan in Treating Patients With Advanced Non-small Cell Lung Cancer
  70. NCT00004925Liposomal Doxorubicin and Trastuzumab in Treating Women With Locally Advanced…
  71. NCT00004926ILX23-7553 in Treating Patients With Solid Tumors That Have Not Responded to Previous…
  72. NCT00004927BMS-247550 in Treating Patients With Advanced Solid Tumors That Have Not Responded to…
  73. NCT00004928Calcitriol and Zoledronate in Treating Patients With Progressive Prostate Cancer
  74. NCT00004929Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer
  75. NCT00004930Inhaled Doxorubicin in Treating Patients With Primary Lung Cancer or Lung Metastases
  76. NCT00004931Fluorouracil Plus Leucovorin With or Without Oxaliplatin in Treating Patients With Stage…
  77. NCT00004932STI571 in Treating Patients With Recurrent Leukemia
  78. NCT00004933Homoharringtonine Compared With Hydroxyurea for Chronic Myelogenous Leukemia That Has Not…
  79. NCT00004934Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB…
  80. NCT00004935Herceptin Followed by Chemotherapy in Treating Women With Metastatic Breast Cancer That…
  81. NCT00004936MRI and CT Scans to Evaluate Invasive Cervical Cancer Before Treating Patients
  82. NCT00004937Acridine Carboxamide in Treating Patients With Recurrent Glioblastoma Multiforme
  83. NCT00004938Phase II Study of Fluconazole for Lymphocutaneous and Visceral Sporotrichosis
  84. NCT00004939Phase III Randomized, Double-Blind, Placebo-Controlled Study of 3,4-Diaminopyridine for…
  85. NCT00004940Phase III Study of L-Cysteine in Patients With Erythropoietic Protoporphyria
  86. NCT00004941Phase III Randomized Study of Anti-Tumor Necrosis Factor Chimeric Monoclonal Antibody…
  87. NCT00004978An International Study to Evaluate Recombinant Interleukin-2 in HIV Positive Patients…
  88. NCT00004979Topotecan and Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or…
  89. NCT00004980Repetitive Transcranial Magnetic Stimulation for "Voices"
  90. NCT00004981Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir)
  91. NCT00004982Combination Iron Chelation Therapy
  92. NCT00004983Education and Group Support for Diabetic Hispanics
  93. NCT00004984The Diabetes Prevention Trial of Type 1 Diabetes (DPT-1)
  94. NCT00004985Combination Treatment Using Capravirine (AG1549), Nelfinavir, and Two Nucleoside Reverse…
  95. NCT00004986Safety and Effectiveness of Nitazoxanide for the Treatment of Cryptosporidiosis in AIDS…
  96. NCT00004987Treatment of Advanced AIDS Patients With Dextrin Sulfate
  97. NCT00004988Treatment of Patients With Cancer With Genetically Modified Salmonella Typhimurium…
  98. NCT00004990Once-A-Month Steroid Treatment for Patients With Focal Segmental Glomerulosclerosis
  99. NCT00004991Study of Brain Activity During Speech Production and Speech Perception
  100. NCT00004992Diabetes Prevention Program
  101. NCT00004993Can Parathyroid Hormone Injections Reverse Glucocorticoid-induced Osteoporosis
  102. NCT00004994Comparison of Quality of Life in Patients Undergoing More Intensive Versus Less Intensive…
  103. NCT00004996Comparison of Immune Response in Normal Volunteers and Patients With Helminth Infections
  104. NCT00004997Leucovorin for the Treatment of 5 q Minus Syndrome
  105. NCT00004998Safety and Effectiveness of a New Anti-HIV Drug (AG1549) in Combination With Other…
  106. NCT00004999Effectiveness of a New Anti-HIV Drug (AG1549) Plus Viracept (Nelfinavir) Plus Combivir…
  107. NCT00005000Treatment With Nelfinavir or Efavirenz of HIV-Infected Patients Who Have Never Received…
  108. NCT00005001Safety and Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune)
  109. NCT00005002Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune)
  110. NCT00005003Genetic Component of Handedness
  111. NCT00005004Brain Processing of Language Meanings
  112. NCT00005005PaTH Study: Parathyroid Hormone and Alendronate for Osteoporosis
  113. NCT00005006Parathyroid Hormone (PTH) With Alendronate for Osteoporosis
  114. NCT00005007Etanercept for Wegener's Granulomatosis
  115. NCT00005009Evaluation of the Safety of Varivax® in Pediatric Renal Transplant Recipients
  116. NCT00005010Prevention of Kidney Transplant Rejection
  117. NCT00005011Combined Hormone Replacement in Menstrually-Related Mood Disorders
  118. NCT00005012Safety and Effectiveness of PEG-Intron in HIV-Infected Patients
  119. NCT00005013Treatment of Major Depression With St. John's Wort (Hypericum)
  120. NCT00005014Treatment of Autism in Children and Adolescents
  121. NCT00005015Treatment of Depression in Youth With Bipolar Disorders
  122. NCT00005016Study of the Experiences and Needs of Parents Continuing a Pregnancy Following a Prenatal…
  123. NCT00005017Effectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva…
  124. NCT00005018Safety and Effectiveness of a Combination Anti-HIV Drug Treatment
  125. NCT00005020Observing Patients With Early HIV Infection
  126. NCT00005021Combination Chemotherapy With or Without Biological Therapy in Treating Patients With…
  127. NCT00005022Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Small Cell Lung…
  128. NCT00005023Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Cancer
  129. NCT00005024Granisetron to Prevent Nausea and Vomiting After Chemotherapy in Patients With Malignant…
  130. NCT00005025Gene Therapy in Treating Women With Refractory or Relapsed Ovarian Epithelial Cancer…
  131. NCT00005026Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian…
  132. NCT00005027Rebeccamycin Analog in Treating Patients With Advanced Kidney Cancer
  133. NCT00005028Paclitaxel and Bryostatin 1 in Treating Patients With Metastatic Prostate Cancer
  134. NCT00005029Topotecan in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal…
  135. NCT00005030SCH 66336 Before Surgery in Treating Patients With Colorectal Cancer That Has Metastasized…
  136. NCT00005031Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer
  137. NCT00005032Bcl-2 Antisense Oligodeoxynucleotide G3139 and Paclitaxel in Treating Patients With…
  138. NCT00005033Trastuzumab in Treating Patients With Recurrent Osteosarcoma
  139. NCT00005035Oxaliplatin in Treating Patients With Advanced Head and Neck Cancer
  140. NCT00005036Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced…
  141. NCT00005037Temozolomide in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell…
  142. NCT00005038Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With…
  143. NCT00005039Vaccine Therapy in Treating Patients With Advanced Adenocarcinoma of the Prostate…
  144. NCT00005040Arsenic Trioxide in Treating Patients With Relapsed or Refractory Non- Hodgkin's Lymphoma
  145. NCT00005041R115777 in Treating Patients With Relapsed Small Cell Lung Cancer
  146. NCT00005042SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma
  147. NCT00005044Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
  148. NCT00005045Carboxyamidotriazole in Treating Patients With Advanced Kidney Cancer
  149. NCT00005046Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal…
  150. NCT000050474B951, Combination Chemotherapy in Treating Patients With Bladder Cancer
  151. NCT00005048Estramustine and Paclitaxel in Treating Patients With Prostate Cancer That Has Not…
  152. NCT00005049Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or…
  153. NCT00005050Eniluracil, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Colorectal…
  154. NCT00005051Combination Chemotherapy in Treating Patients With Advanced Ovarian Epithelial Cancer
  155. NCT00005052Vaccine Therapy in Treating Patients With Primary Stage II Melanoma
  156. NCT00005053Glufosfamide With or Without Hydration in Treating Patients With Advanced Pancreatic…
  157. NCT00005054Temozolomide in Treating Women With Advanced Breast Cancer
  158. NCT00005055Glufosfamide With of Without Hydration in Treating Patients With Advanced Non-small Cell…
  159. NCT00005056Bryostatin 1 In Treating Patients With Progressive Kidney Cancer
  160. NCT00005057Gene Therapy and Ganciclovir in Treating Patients With Stage IV Melanoma
  161. NCT00005058Enhanced Ultrasound in Determining Extent of Disease in Women With Primary Breast Cancer
  162. NCT00005059Carboplatin and Paclitaxel in Treating Older Patients With Metastatic or Recurrent…
  163. NCT00005060Combination Chemotherapy and Surgery in Treating Patients With Locally Advanced Stomach…
  164. NCT00005061Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Solid Tumors
  165. NCT00005062Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer in Complete…
  166. NCT00005064PS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute…
  167. NCT00005065Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage IIIA…
  168. NCT00005066O6-benzylguanine and Carmustine in Treating Patients With Recurrent, Metastatic, or…
  169. NCT00005067Photodynamic Therapy With Lutetium Texaphyrin in Treating Patients With Locally Recurrent…
  170. NCT00005068Combination Chemotherapy In Treating Patients With Metastatic or Unresectable Solid Tumors
  171. NCT00005069Arsenic Trioxide in Treating Patients With Metastatic Kidney Cancer
  172. NCT00005070Irofulven in Treating Patients With Stage IVB or Recurrent Cervical Cancer
  173. NCT00005071Diagnosis and Treatment Planning in Patients Suspected of Having Lung Cancer
  174. NCT00005072Leuvectin in Treating Patients With Locally Recurrent Prostate Cancer
  175. NCT00005073Zoledronate Plus Standard Therapy Compared With Placebo Plus Standard Therapy to Prevent…
  176. NCT00005074Flavopiridol in Treating Patients With Previously Untreated or Relapsed Mantle Cell…
  177. NCT00005075Ultrasound in Treating Patients With Recurrent Stage I or Stage II Prostate Cancer
  178. NCT00005076Cetuximab and Irinotecan in Treating Patients With Advanced Colorectal Cancer
  179. NCT00005077Oxaliplatin in Treating Patients With Advanced Cancer Plus Liver Dysfunction
  180. NCT00005078Tirapazamine, Carboplatin, and Paclitaxel in Treating Patients With Advanced Malignant…
  181. NCT00005079Timing of Menstrual Cycle and Surgery in Treating Premenopausal Women With Stage I, Stage…
  182. NCT00005080506U78 in Treating Patients With Lymphoma
  183. NCT00005081Carmustine Plus O6-benzylguanine in Treating Patients With Recurrent or Progressive Glioma
  184. NCT00005082Magnetic Resonance Imaging in Determining Extent of Cancer in Patients With Newly…
  185. NCT00005083Functional Magnetic Resonance Imaging and 1H-Nuclear Magnetic Resonance Spectroscopic…
  186. NCT00005084Magnetic Resonance Imaging in Treating Children With Progressive Low-Grade Astrocytoma
  187. NCT00005085Rebeccamycin Analog in Treating Patients With Metastatic or Locally Recurrent Colorectal…
  188. NCT00005086Combination Chemotherapy in Treating Patients With Stage IV Locally Advanced or Metastatic…
  189. NCT00005087Paclitaxel, Cisplatin, and Filgrastim Combined With Radiation Therapy in Treating Patients…
  190. NCT00005088Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck Cancer
  191. NCT00005089S0014 Combination Chemotherapy Plus Rituximab and Radiation Therapy in Treating Patients…
  192. NCT00005090S9901 Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in…
  193. NCT00005091DX-8951f in Treating Previously Untreated Patients With Stage IIIB or Stage IV Non-small…
  194. NCT00005092Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating…
  195. NCT00005093Gemcitabine With or Without CI-994 in Treating Patients With Advanced Non-small Cell Lung…
  196. NCT00005094Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove…
  197. NCT00005095Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
  198. NCT00005096Docetaxel in Treating Patients With Stage II or Stage III Prostate Cancer
  199. NCT00005097Green Tea Extract in Treating Patients With Actinic Keratosis
  200. NCT00005098Study of Genotype and Phenotype in Patients With Alpha 1-Antitrypsin Deficiency
  201. NCT00005100Measurement of Outcome of Surgical Treatment in Patients With Acromegaly
  202. NCT00005101Study of Low Bone Mass in Premenopausal or Perimenopausal Women
  203. NCT00005102Immunologic Evaluation in Patients With DiGeorge Syndrome or Velocardiofacial Syndrome
  204. NCT00005103Study of the Pathogenesis of Porphyria Cutanea Tarda
  205. NCT00005104Randomized Study of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene…
  206. NCT00005105Genetic Study of Insulin-Like Growth Factor-I Receptor Mutations in Patients With…
  207. NCT00005106A Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients
  208. NCT00005107Role of Nitric Oxide in Cirrhosis: Relationship With Systemic Hemodynamics, Renal…
  209. NCT00005108Effects of Hormone Replacement Therapy on Inflammation and Stiffening of Artery Walls
  210. NCT00005110A Multi-Centered Study of the Long-Term Effect of Salmeterol and Albuterol in Cystic…
  211. NCT00005111PET Scans in Normal Volunteers and Patients With Fabry Disease
  212. NCT00005112Growth Hormone Use in Cystic Fibrosis - a Multicenter Study
  213. NCT00005113A Study to Compare Treatment With Sirolimus Versus Standard Treatment in Patients Who Have…
  214. NCT00005116Depression In Juvenile Diabetics
  215. NCT00005117Effect of Pravastatin on Endothelial Dysfunction Following a Single High Fat Meal
  216. NCT00005118The Safety and Effectiveness of Indinavir Plus Ritonavir Plus Two NRTIs in HIV-Infected…
  217. NCT00005119Altered Calcium and Vitamin D in PMDD or Severe PMS
  218. NCT00005120The Safety and Effectiveness of (+)-Calanolide A in HIV-Infected Patients Who Have Never…
  219. NCT00005121Framingham Heart Study
  220. NCT00005122Evans County Studies
  221. NCT00005123Honolulu Heart Program
  222. NCT00005124National Heart, Lung, and Blood Institute Twin Study
  223. NCT00005125NAS-NRC Twin Registry
  224. NCT00005126Vietnam Era Twin (VET) Registry
  225. NCT00005127Muscatine Heart Study
  226. NCT00005128Lipid Research Clinics Population Studies
  227. NCT00005129Bogalusa Heart Study
  228. NCT00005130Coronary Artery Risk Development in Young Adults
  229. NCT00005131Atherosclerosis Risk in Communities (ARIC)
  230. NCT00005132National Growth and Health Study (NGHS)
  231. NCT00005133Cardiovascular Health Study (CHS)
  232. NCT00005134Strong Heart Study
  233. NCT00005135Insulin Resistance Atherosclerosis Study (IRAS)
  234. NCT00005136Family Heart Study (FHS)
  235. NCT00005137Heritage Study--Genetics, Exercise and Risk Factors
  236. NCT00005138High Blood Pressure in the Young
  237. NCT00005139Characterization Of Coronary Prone Pedigrees
  238. NCT00005140Epidemiology of Cardiovascular and Non-Cardiovascular Risk In Chicago
  239. NCT00005141Minneapolis Children's Blood Pressure Study
  240. NCT00005142Etiology and Prevalence of Peripheral Arterial Disease
  241. NCT00005143Stanford Five-City Multifactor Risk Reduction Study
  242. NCT00005144Coronary-Prone Behavior and Cardiovascular Reactivity
  243. NCT00005145Minnesota Heart Survey - Risk Factor Survey
  244. NCT00005146Diabetes and Cardiovascular Risk In Mexico City (San Antonio Heart Study)
  245. NCT00005147Epidemiology of Atherosclerosis
  246. NCT00005148Coronary Heart Disease Incidence, Mortality, and Risk Factor Relationships
  247. NCT00005149Genetic and Environmental Determinants of Hypertension
  248. NCT00005150Minnesota Heart Health Program
  249. NCT00005151Pawtucket Heart Health Program
  250. NCT00005152Nurses' Health Study (Cardiovascular Component)
  251. NCT00005153Etiologic Risk Factors of Cardiovascular Malformations
  252. NCT00005154National Health and Nutrition Examination Survey IV (NHANES (IV)
  253. NCT00005155Physiological and Psychosocial Correlates of Type A Behavior
  254. NCT00005156Mortality Surveillance of MRFIT Screenees
  255. NCT00005157Speech Characteristics in Coronary Heart Disease
  256. NCT00005158Segregation/Linkage Analysis for Hypertension
  257. NCT00005159National Longitudinal Mortality Study (NLMS)
  258. NCT00005160Epidemiology of Cardiovascular Risk Factors in Women (Healthy Women Study)
  259. NCT00005161Longitudinal Twin Study - Cohort Study of Blood Pressure
  260. NCT00005162Epidemiology of Decline in Heart Disease Mortality
  261. NCT00005163Validation and Field Test for Risk Appraisal Instruments
  262. NCT00005164Insulin Resistance and Blood Pressure Regulation in Blacks
  263. NCT00005165Charleston Heart Study - Predictors of Coronary Disease in Blacks
  264. NCT00005166Sodium Transport: Genetics and Hypertension
  265. NCT00005167Diet Modification and Blood Pressure in Young People
  266. NCT00005168Hyperapo B and Coronary Heart Disease
  267. NCT00005169Lifestyle and Chronic Disease in College Alumni (Harvard Alumni Health Study)
  268. NCT00005170Ambulatory Blood Pressure and Behavior
  269. NCT00005171Cardiovascular Risk Factors in United States Adolescents and Adults
  270. NCT00005172Socioeconomic Status, John Henryism and Hypertension Risk in Blacks
  271. NCT00005173Myocardial Infarction and Past Oral Contraceptive Use
  272. NCT00005174Western Collaborative Group Study (WCGS): 25-Year Follow-up of Cardiovascular Disease…
  273. NCT00005175Coronary Heart Disease Risk Factors in Upwardly Mobile Blacks and Whites
  274. NCT00005176Long QT Syndrome-Population Genetics and Cardiac Studies
  275. NCT00005177Reno Diet Heart Study
  276. NCT00005178Study of Children's Activity and Nutrition (SCAN)
  277. NCT00005179Diet, Exercise and Cardiovascular Health Among Ethnic Children
  278. NCT00005180End-organ Pathology in Childhood Essential Hypertension
  279. NCT00005181Blood Pressure Control in Juveniles - Longitudinal Study
  280. NCT00005182Health Professionals Follow-up Study
  281. NCT00005183Apolipoprotein A-I Gene Polymorphism and Atherosclerosis
  282. NCT00005184Immunogenetic Factors of Coronary Heart Disease
  283. NCT00005185Myocardial Infarction and Non-contraceptive Estrogen Use
  284. NCT00005186Epidemiology of Cardiovascular Diseases in The Elderly
  285. NCT00005187Cardiovascular Risk Profile Among Mexican-Americans
  286. NCT00005188Quantitative Genetic Analysis of Lipid Research Clinic Family Data
  287. NCT00005189Carotid Atherosclerosis Follow-up Study
  288. NCT00005190Reproduction and Survival After Cardiac Defect Repair
  289. NCT00005191Clinical Course of Coronary Artery Disease Among Blacks
  290. NCT00005192Psychophysiology of Cardiovascular Reactivity
  291. NCT00005193Prospective Study of Diabetes-related Vascular Disease in Oklahoma Indians
  292. NCT00005194Insulin and Biogenic Amines in Cardiovascular Disease
  293. NCT00005195Catheter Ablation Registry
  294. NCT00005196Worcester Heart Attack Community Surveillance Study
  295. NCT00005197Predictors of Perioperative Cardiac Morbidity
  296. NCT00005198Survival After Myocardial Infarction in A Biethnic Texas Community (Corpus Christi Heart…
  297. NCT00005199Balloon Valvuloplasty Registry
  298. NCT00005200Adolescent Blood Pressure Variation and Ventricular Mass
  299. NCT00005201Idiopathic Dilated Cardiomyopathy
  300. NCT00005202Identifying High Risk Patients With Syncope
  301. NCT00005203Genetics of Low Density Lipoprotein Subclasses in Hypercholesterolemia
  302. NCT00005204Blood Pressure and Diurnal Variation in Sodium, Potassium, and Water Excretion
  303. NCT00005205Incidence of Diabetes and Cardiovascular Disease in Mexican Americans
  304. NCT00005206Calcium Intake, Metabolism, and Gestational Blood Pressure
  305. NCT00005207Renin and Prorenin in Pregnancy
  306. NCT00005208Regulation of Placental Vascular Reactivity in Pregnancy-induced Hypertension
  307. NCT00005209Genetic Epidemiology of Coronary Heart Disease
  308. NCT00005210Sex Steroids, Obesity and Lipids in Adolescent Females
  309. NCT00005211Cardiovascular Mortality Among Tunnel and Bridge Workers Exposed To Carbon Monoxide
  310. NCT00005212Work Organization and Cardiovascular Disease
  311. NCT00005213Lithium Countertransport and Blood Pressure In CARDIA and TOMHS
  312. NCT00005214Epidemiology of Genetic Factors in Lipid Metabolism
  313. NCT00005215Lipoprotein Subfractions and Coronary Heart Disease During 25 Year Follow-up
  314. NCT00005216Multicenter Study of Silent Myocardial Ischemia (MSSMI)
  315. NCT00005217Intermittent ST Depression and Prognosis After Myocardial Infarction
  316. NCT00005218Epidemiological Tool To Detect Angina Pectoris in Blacks
  317. NCT00005219Predicting Physical Activity Change: an Epidemiologic Study
  318. NCT00005220Postmenopausal Progestins, MI and Stroke
  319. NCT00005221Analysis of Longitudinal Cardiopulmonary Data
  320. NCT00005222Decline in Cardiovascular Mortality: Framingham 1950-1984
  321. NCT00005223Epidemiology of APO- and Lipoproteins in Elderly Women
  322. NCT00005224Gender Response To Coronary Risk
  323. NCT00005225Apolipoprotein Polymorphisms and Risk of Coronary Heart Disease
  324. NCT00005226Epidemiology of Plasma Fatty Acids and Atherosclerosis
  325. NCT00005227AIDS-Associated Cardiomyopathy
  326. NCT00005228AIDS-Associated Heart Disease -- Incidence and Etiology
  327. NCT00005229HIV-Associated Heart Disease
  328. NCT00005230Epidemiology of Carotid Disease in Elderly Adults
  329. NCT00005231Development, Testing, and Validation of A Protocol To Assess Cardiovascular Reactivity in…
  330. NCT00005232Gubbio Study Five-year Follow-up: Lithium Countertransport, Blood Pressure, and Other…
  331. NCT00005233Patterns of Fatty Acids in Framingham Offspring
  332. NCT00005234Cardiovascular Disease in Black Versus White Physicians
  333. NCT00005235Heart Rate Variability and Sudden Cardiac Death
  334. NCT00005236Atherosclerosis and Omega-3 Fatty Acids in Alaskan Natives
  335. NCT00005237Epidemiology of Symptomatic Arrhythmias
  336. NCT00005238Antecedents of Hypertension: Role of Race and Stress
  337. NCT00005239Genetic Epidemiology of Coronary Heart Disease Risk in Women Twins
  338. NCT00005240Epidemiology of Hypertensive Emergency
  339. NCT00005241Myocardial Infarction and Current Oral Contraceptive Use
  340. NCT00005242Childhood Passive Smoking: Cohort Study of Cardiac Risk
  341. NCT00005243Triggers of Ventricular Arrhythmias (TOVA) Study
  342. NCT00005244Anger Expression, Self-focus and Coronary Heart Disease Risk Factors
  343. NCT00005245Community Structure and Cardiovascular Mortality Trends
  344. NCT00005246Epidemiology of Insulin and Dehydroepiandrosterone Sulfate and Coronary Heart Disease…
  345. NCT00005247Nutritional Determinants of Cardiovascular Disease
  346. NCT00005248Adiposity and Fat Patterning in Black Americans
  347. NCT00005249Epidemiology of Blood Pressure, Insulin, Salt Transport
  348. NCT00005250Linkage Study of Long QT Syndrome In An Amish Kindred
  349. NCT00005251Genetic Analysis of Familial Hypertrophic Cardiomyopathy
  350. NCT00005252Physicians' Health Study: Study of Low Cardiovascular Disease Mortality
  351. NCT00005253Proarrhythmic Medicines and Primary Cardiac Arrest
  352. NCT00005254Natural History of Peripheral Arterial Disease
  353. NCT00005255Ischemic Heart Disease Incidence and Indices of Body-fat Distribution
  354. NCT00005256Coronary Screening in a High Risk Subset
  355. NCT00005257Diet and Plasma Cholesterol - Secular Trend Analysis
  356. NCT00005258Family Study of Congenital Cardiovascular Malformations
  357. NCT00005259Polyunsaturated Fats and Risk of Primary Cardiac Arrest
  358. NCT00005260Mechanisms Underlying Psychosocial Associations With Ischemic Heart Disease (Kuopio)
  359. NCT00005261Urinary Kallikrein and Hypertension: A Prospective Study
  360. NCT00005262Epidemiology of Idiopathic Dilated Cardiomyopathy (Washington, DC Dilated Cardiomyopathy…
  361. NCT00005263Postprandial Lipoproteins and Atherosclerosis
  362. NCT00005264Pediatric Epidemiology of Cardiovascular Disease Risk Factors (Project Heartbeat)
  363. NCT00005265Natural History of Coronary Heart Disease
  364. NCT00005266Cardiovascular Disease Mortality in The NAS-NRC Twin Registry
  365. NCT00005267Family Blood Pressure Program - HyperGEN
  366. NCT00005268Family Blood Pressure Program - GenNet Network
  367. NCT00005269Family Blood Pressure Program - GENOA
  368. NCT00005270Family Blood Pressure Program - SAPPHIRe Network
  369. NCT00005271INTERMAP: International Population Study on Macronutrients and BP
  370. NCT00005272Smoking and Body Weight: Analysis of HHANES
  371. NCT00005273Pulmonary Complications of HIV Infection Study (PACS)
  372. NCT00005274Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV…
  373. NCT00005275Sleep Heart Health Study (SHHS) Data Coordinating Center
  374. NCT00005276A Case Controlled Etiologic Study of Sarcoidosis (ACCESS)
  375. NCT00005277Cooperative Study of The Clinical Course of Sickle Cell Disease
  376. NCT00005278Retrovirus Epidemiology Donor Study I (REDS I)
  377. NCT00005279Tucson Epidemiology Study of Chronic Obstructive Lung Diseases
  378. NCT00005280Specialized Center of Research in Occupational and Immunologic Lung Disease
  379. NCT00005281Early Risk Predictors For Chronic Pulmonary Disease
  380. NCT00005282Prospective Evaluation of Airways Reactivity
  381. NCT00005283Risk Factors For Asthma in Laboratory Animal Allergy
  382. NCT00005284Epidemiology of Airway Responsiveness
  383. NCT00005285Effect of Maternal Smoking On Neonatal Lung Function
  384. NCT00005286Epidemiology of Sleep Apnea Syndrome
  385. NCT00005287Late Sequelae of Bronchopulmonary Dysplasia
  386. NCT00005288Epidemiology and Pulmonary Response To Organic Dust Exposure
  387. NCT00005289Risk Factors in Bronchopulmonary Dysplasia (Newborn Lung Project)
  388. NCT00005290Epidemiology of Interstitial Lung Disease
  389. NCT00005291Clinical Epidemiology of Asthma in An HMO
  390. NCT00005292Alpha1-antitrypsin Deficiency Registry
  391. NCT00005293Antecedents of Bronchopulmonary Dysplasia
  392. NCT00005294Developmental Sequelae of Severe Chronic Lung Disorders
  393. NCT00005295Idiopathic Pulmonary Fibrosis: a Case-control Study
  394. NCT00005296Sleep Apnea: Age Effects On Prevalence and Natural History
  395. NCT00005297Age-related Prevalence of Sleep Respiratory Disturbances
  396. NCT00005298Inflammation, Autonomic Dysfunction and Airway Disease
  397. NCT00005299Familial Aggregation and Natural History of Sleep Apnea
  398. NCT00005300Investigation of Selected Patient Groups From The Cooperative Study of Sickle Cell Disease
  399. NCT00005301Transfusion Safety Study (TSS)
  400. NCT00005302Drug Etiology of Aplastic Anemia and Related Dyscrasias
  401. NCT00005303Effectiveness of AIDS Antibody Screening
  402. NCT00005304Delta Hepatitis and Liver Disease in Hemophiliacs
  403. NCT00005305Hepatitis Delta Infections in Hemophiliacs
  404. NCT00005306Natural History of Post-transfusion Non-A, Non-B Hepatitis
  405. NCT00005307Etiology of Blood Dyscrasias: Analysis of the International Agranulocytosis and Aplastic…
  406. NCT00005308Anemia and Surgery: Indications For Transfusion
  407. NCT00005309Prospective Study of HIV Infection in Hemophiliacs
  408. NCT00005311Hypertension in Minorities Database-Workshop and Publication
  409. NCT00005312International Programs Collaborative Studies Coordinating Center
  410. NCT00005313Human Lipoprotein Pathophysiology - Subproject: Genetics of Familial Combined…
  411. NCT00005314Behavioral Factors in Coronary Heart Disease
  412. NCT00005315Psychosocial Factors and Cardiovascular Disease
  413. NCT00005316White Coat Hypertension and Antihypertensive Treatment Effect - SCOR in Hypertension
  414. NCT00005317Idiopathic Pulmonary Fibrosis--Pathogenesis and Staging - SCOR in Occupational and…
  415. NCT00005318ARDS - Clinical Epidemiology and the Role of the Inflammatory Response - SCOR in Acute…
  416. NCT00005319Epidemiologic Studies of Blood Use in the United States - SCOR in Transfusion Medicine
  417. NCT00005320Regulation of Pharyngeal Muscle Contraction - SCOR in Cardiopulmonary Disorders of Sleep
  418. NCT00005321Epidemiology of Sleep Disordered Breathing - SCOR in Cardiopulmonary Disorders of Sleep
  419. NCT00005322Molecular Genetic Epidemiology of Endocardial Cushion Defects - SCOR in Pediatric…
  420. NCT00005323Epidemiology of Persistent Pulmonary Hypertension of the Newborn - SCOR in Lung Biology…
  421. NCT00005324Genetic and Epidemiologic Studies of Premature Coronary Artery Disease - SCOR in…
  422. NCT00005325Identifying Genes Involved in Abnormal Blood Pressure - Hypertension SCOR
  423. NCT00005326Cerebrovascular Involvement in Sickle Cell Disease - Comprehensive Sickle Cell Center
  424. NCT00005327Prevention of Cerebral Infarction in Sickle Cell Anemia - Comprehensive Sickle Cell Center
  425. NCT00005328Antecedents of the Type A Behavior Pattern
  426. NCT00005329Protein S and Myocardial Infarction
  427. NCT00005330Framingham Children's Study - Food and Exercise Habits in Framingham Study Descendents
  428. NCT00005331Providers for Smoking Prevention Programs
  429. NCT00005332Antihypertensive Drug/Gene Interactions and CV Events
  430. NCT00005333Epidemic Hypertension in Nigerian Workers
  431. NCT00005334Effects of Personality and Context on Recovery From Coronary Artery Bypass
  432. NCT00005335Genetic Epidemiology of Lipoprotein-Lipid Levels
  433. NCT00005336Dietary Treatment of Hyperlipidemia in Women vs. Men
  434. NCT00005337Hostility and Coronary Risk--Role of Weak Vagal Function
  435. NCT00005338Homocysteine and Progression of Atherosclerosis
  436. NCT00005339Risk of Post Transfusion Hepatitis C Virus Infection
  437. NCT00005340Hypertension in Blacks of West African Origin
  438. NCT00005341Blood Donation--Immune Sequelae and Recruitment
  439. NCT00005342Weight Set-Point and HDL Concentration in Runners
  440. NCT00005343Social Support and CHD Risk Factors--A Community Study
  441. NCT00005344Mediators of Social Support in Coronary Disease
  442. NCT00005345Genetic Epidemiology of Blood Lipids and Obesity - Ancillary to NGHS
  443. NCT00005346Mechanisms Underlying Abnormal Ambulatory BP Patterns
  444. NCT00005347Framingham Cycle V Offspring-Spouse Nutrition Studies
  445. NCT00005348Adipose Distribution and Atherosclerosis
  446. NCT00005349Epidemiology of Coronary Artery Calcification
  447. NCT00005350Evaluating Strategies to Control Hypercholesterolemia
  448. NCT00005351Incidence and Outcomes of Venous Thromboembolism
  449. NCT00005352Chronic Stress as a Risk Factor in the Etiology of Coronary Heart Disease
  450. NCT00005353Cardiac Autonomic Control in Children of HIV Positive Mothers
  451. NCT00005354Computed Tomography (CT)--An Epidemiologic Study in the Young
  452. NCT00005355Gender Differences in Familial Risk
  453. NCT00005356Novel Hemostatic Cardiac Risk Factors in Framingham
  454. NCT00005357Pulmonary Hypertension--Mechanisms and Family Registry
  455. NCT00005358Thrombogenic Factors and Recurrent Coronary Events
  456. NCT00005359Genetics of Asthma and Bronchial Hyperresponsiveness
  457. NCT00005360HIV Diversity and Pathogenesis in Donor-Recipient Clusters
  458. NCT00005361Determinants of Respiratory Health in Young Adults
  459. NCT00005362Dose Estimation for Studies of Acute Respiratory Effects
  460. NCT00005363Ambulatory Blood Pressure and Prognosis
  461. NCT00005364Genetic Epidemiology of CHD Risk Factors in Blacks
  462. NCT00005365Central Obesity and Disease Risk in Japanese Americans
  463. NCT00005366Biobehavioral Mechanisms of Blood Pressure Regulation
  464. NCT00005367Epidemiology of Long QTand Asian Sudden Death in Sleep
  465. NCT00005368Genetic Epidemiology of Hypertriglyceridemia
  466. NCT00005369Coronary Artery Disease Mechanisms in High Risk Families--Racial Difference
  467. NCT00005370Longitudinal Study of Cortisol and Pulmonary Function
  468. NCT00005371Epidemiology of Acute Phase Protein and CHD
  469. NCT00005372Intimal Thickening and Antioxidants in Hispanics and Anglos (Los Angeles Atherosclerosis…
  470. NCT00005373Racial Differences in the Coronary Microcirculation
  471. NCT00005374Genetics of the Metabolic Syndrome in Japanese Americans
  472. NCT00005375Smoking Onset in a Biethnic Population
  473. NCT00005376Premature Birth and Its Sequelae in Women
  474. NCT00005377Molecular Epidemiology of Essential Hypertension
  475. NCT00005378Impact of Sleep Disordered Breathing in Older Adults
  476. NCT00005379Tuberculosis in a Multiethnic Inner City Population
  477. NCT00005380Insulin, Androgen, and Risk in African-American Women
  478. NCT00005381Prevalence of Sleep Apnea in Women
  479. NCT00005382Sources of Variability in Peak Expiratory Flow
  480. NCT00005383Anger and Cardiovascular Risk in Urban Youth
  481. NCT00005384Diet/Activity of Mexican American and Anglo Children
  482. NCT00005385Seasonal Variation of Blood Cholesterol Levels
  483. NCT00005386Biobehavioral Determinants of Obesity in Black Women
  484. NCT00005387Genetics of Hypertension in Blacks
  485. NCT00005388Visceral Fat, Metabolic Rate, and CHD Risk in Young Adults
  486. NCT00005389Effect of Drug Therapy on Reinfarction Risk in Women
  487. NCT00005390Family Process, Adherence, and Child Asthma Outcome
  488. NCT00005391Pediatric Cardiomyopathy Registry
  489. NCT00005392Epidemiology of Venous Disease
  490. NCT00005393Epidemiology: Oxidative Stress and Early Atherosclerosis
  491. NCT00005394Diagnosis/Pathophysiology of Glucocorticoid Remediable Aldosteronism Hypertension
  492. NCT00005395Honolulu Heart Program-Study of Stroke and Dementia
  493. NCT00005396Motivating Smokers--Reduce Child Environmental Tobacco Smoke Exposure
  494. NCT00005397Epidemiology of Carotid Artery Atherosclerosis in Youth
  495. NCT00005398University of North Carolina Alumni Heart Study
  496. NCT00005399Cohort Study of Heart Rate Variability
  497. NCT00005400Angiotensinogen Variants and Adverse Pregnancy Outcomes
  498. NCT00005401Validation and Exploration of Sleep and Mood Predictors
  499. NCT00005402Transfusion Associated HCV in a Pediatric Population
  500. NCT00005403Heart Disease and the Black Health Disadvantage
  501. NCT00005404Compliance in the Physicians' Health Study
  502. NCT00005405Parity and Serum Lipids in White and Hispanic Women
  503. NCT00005406Change in Coronary Heart Disease Risk Factors in Young Adults
  504. NCT00005407Statistical Analysis of Pediatric Task Force Data Base
  505. NCT00005408Reanalysis of CVD Risk Factors Via Likelihood Methods
  506. NCT00005409Longitudinal Studies of Blood Pressure in the Elderly
  507. NCT00005410Epidemiology of Coronary Heart Disease in Blacks
  508. NCT00005411Study of Children's Activity and Nutrition (SCAN)--Extended Analyses
  509. NCT00005412Dietary Antioxidants and Atherosclerosis
  510. NCT00005413Stroke Risk in the NAS-NRC Twin Registry
  511. NCT00005414Validation of a Historical Physical Activity Survey
  512. NCT00005415Physical Activity Effects on Health Care Utilization
  513. NCT00005416Diet, Exercise, and Cardiovascular Health Among Ethnic Children
  514. NCT00005417Fifteen Year Follow-up of 5,500 Black and 5,500 Other Hypertensives
  515. NCT00005418Epidemiology of Cardiotoxicity in Children With Cancer
  516. NCT00005419Physical Activity, Hypertension, Diabetes, and Coronary Heart Disease
  517. NCT00005420Prediction of Quality of Life in Cardiovascular Disease
  518. NCT00005421Blood Pressure Tracking--Childhood to Young Adulthood
  519. NCT00005422Longitudinal Analysis of Spirometry in Black Children
  520. NCT00005423Dietary Quality and Subsequent Cardiovascular Disease
  521. NCT00005424Prospective Analysis of the Effect of Widowhood on CVD
  522. NCT00005425Statistical Analysis of Vlagtwedde-Vlaardingen Data Set
  523. NCT00005426Effects of CHD Prevention on Lipoprotein Subclasses
  524. NCT00005427Cohort Study of Respiratory Illness in Early Childhood
  525. NCT00005428Familial Aggregation of Stress Response
  526. NCT00005429Clinical Cardiovascular Outcomes of African-Americans
  527. NCT00005430Low Cholesterol and Mortality in Blacks and Women
  528. NCT00005431Coronary Heart Disease Risk Factors in Blacks Vs Whites
  529. NCT00005432Impact of Surfactant's Availability on Newborns
  530. NCT00005433Correlates of Angiographic Changes and Coronary Events
  531. NCT00005434Opioid Compromise in Hypertension--Modulating Factors
  532. NCT00005435Hostility and Pathogenic Mechanisms of Coronary Heart Disease in Women
  533. NCT00005436Lupus Cohort--Thrombotic Events and Coronary Artery Disease
  534. NCT00005437Physical Activity and Cardiovascular Risk in Black Girls
  535. NCT00005438Neuropsychological Studies of Children With Sickle Cell
  536. NCT00005439Evaluation of Childhood Blood Pressure and Lipid Screening
  537. NCT00005440Disability Among Adults With Asthma
  538. NCT00005441Lifestyle Management for Women With CHD and NIDDM
  539. NCT00005442Re-evaluating Triglycerides in Coronary Heart Disease
  540. NCT00005443Race, Class, and Gender--Studies of Health Effects
  541. NCT00005444Hypertension in Families of African Origin
  542. NCT00005445Epidemiology of Pediatric Asthma Hospitalization
  543. NCT00005446Endogenous Estrogen and Coronary Heart Disease in Women
  544. NCT00005447Physical Activity and Cardiovascular Disease Prevention
  545. NCT00005448Adverse Events With Magnesium Sulfate
  546. NCT00005449Social Support and Myocardial Ischemia
  547. NCT00005450Health Promotion in the Elderly--Prevention of Cardiovascular Disorders
  548. NCT00005451WINCATI Software Tool for Survey Research
  549. NCT00005452Ti PC Software for Analyzing Longitudinal Data
  550. NCT00005453Adherence in Clinical Trials-Induction Strategies
  551. NCT00005455Chagas Disease as an Undiagnosed Type of Cardiomyopathy in the United States
  552. NCT00005456Hypertensive and Normal Pregnancy--Calcium Metabolism and Renin-Angiotensin - SCOR in…
  553. NCT00005457Model-Free Time Curves for Longitudinal Data Analysis
  554. NCT00005458Suppressed Anger, Blood Pressure and Mortality Follow-up
  555. NCT00005459Risk of Coronary Heart Disease in Women With Polycystic Ovary Syndrome
  556. NCT00005460Predictors of Cardiovascular Disease in the Elderly
  557. NCT00005461Epidemiology of Symptom Perception in Childhood Asthma
  558. NCT00005462Genetics of Atherosclerosis in Mexican Americans
  559. NCT00005463Population-Based Modeling of Cholesterol Lowering in the United States
  560. NCT00005464DISH Data Analysis Study
  561. NCT00005465Genetic Mapping of Atherogenic Lipoprotein Phenotypes
  562. NCT00005466Stroke and MI in Users of Estrogen/Progestogen
  563. NCT00005467Indices of Severity and Prognosis for Sickle Cell Disease
  564. NCT00005468Lipid Variability--Influence of Stress
  565. NCT00005469Maturational Changes in Cardiac Structures -- Blood Pressure Relationship -- SCOR in…
  566. NCT00005470Divergence of Blood Pressure By Race in Adolescent Girls
  567. NCT00005471Anxiety and Cardiovascular Autonomic Control
  568. NCT00005472Job Strain, Ambulatory Blood Pressure and Hypertension
  569. NCT00005473Cardiovascular Disease Trends 1980-91--A Gender Specific Perspective
  570. NCT00005474Markers and Mechanisms of Macrovascular Disease in IDDM
  571. NCT00005475Longitudinal Study of Asthma From Birth to Adulthood
  572. NCT00005476Sociodemographic Regulation of Cardiovascular Function and Structure
  573. NCT00005477Hispanic and White Women's Cardiovascular Health
  574. NCT00005478Precursors of CVD Risk Factors--Project Heartbeat
  575. NCT00005479Diabetes, Lipoproteins and Accelerated Vascular Disease
  576. NCT00005480Cardiovascular Disease Knowledge/Morbidity--Socioeconomic Cohort Outcomes
  577. NCT00005481Epidemiology of Impaired Coagulant Balance in Diabetes
  578. NCT00005482Homocyst(e)Ine, Vitamin Status, and CVD Risk
  579. NCT00005483Plasma Homocysteine Distribution in the United States
  580. NCT00005484Predictors of Hospital-Based Care in Asthma
  581. NCT00005485The Jackson Heart Study of Cardiovascular Disease Among African Americans
  582. NCT00005486Lymphangioleiomyomatosis (LAM) Registry
  583. NCT00005487Multi-Ethnic Study of Atherosclerosis (MESA)
  584. NCT00005488Common Variants in Candidate Genes and Premature MI Risk
  585. NCT00005489Salt Sensitivity, Cardiovascular and Metabolic Disease
  586. NCT00005490Modeling DNA Diversity in Cardiovascular Health/Disease
  587. NCT00005492Pooled Analysis of NHANES I/II--Race, Gender, and CHD
  588. NCT00005493Observational Aspirin Use and CVD in the Physicians' Health Study
  589. NCT00005494Prospective Study of Health in Runners and Walkers
  590. NCT00005495Primary Prevention of CHD Risk Factors Occurring in US
  591. NCT00005496Inflammation, Infection, and Future Cardiovascular Risk
  592. NCT00005497Risk Factors for Pulmonary Hypertension of the Newborn
  593. NCT00005498Do Hostility and Stress Predict Cardiovascular Mortality in MRFIT?
  594. NCT00005499Congestive Heart Failure Trends in the Elderly 1970-94
  595. NCT00005500Collaborative Studies on the Genetics of Asthma (CSGA)
  596. NCT00005501Hypertensive Treatment and Epidemiological Analyses
  597. NCT00005502Coronary Disease Morbidity and Mortality in a Population
  598. NCT00005503Epidemiology of Cardiac Development in Youth
  599. NCT00005504Epidemiology of Venous Thrombosis and Pulmonary Embolism
  600. NCT00005505Neighborhood Environments and Cardiovascular Disease
  601. NCT00005506Vascular Disease--Structure/Function
  602. NCT00005507Race and the Use of Cardiovascular Surgical Procedures
  603. NCT00005508Determinants of Coronary Disease in High Risk Families
  604. NCT00005509Cardiovascular Risk Factors in a Cohort of Latina Women
  605. NCT00005510Strong Heart Study Analyses Obesity and Lipoproteins
  606. NCT00005511SCOR in Neurobiology of Sleep--Intermediate Traits for Sleep Apnea
  607. NCT00005512Genetic Epidemiology--Development of Cardiovascular Risk
  608. NCT00005513Framingham Nutrition Studies
  609. NCT00005514Dietary Patterns and Risk of Cardiovascular Disease
  610. NCT00005515Mutations, Hormone Therapy (HRT) and Venous Thromboembolism
  611. NCT00005516Epidemiology of Sleep Disordered Breathing in Children
  612. NCT00005517Community Surveillance of Congestive Heart Failure
  613. NCT00005518Epidemiology and Immunology of Hemophilia A Inhibitors
  614. NCT00005519Prospective Study of Diet and Cardiovascular Disease
  615. NCT00005520Genetic Epidemiology of Responses to Antihypertensives
  616. NCT00005521Exercise and Blood Pressure in Children: A Meta-Analysis
  617. NCT00005522Social Dominance, Gender, and Cardiovascular Reactivity
  618. NCT00005523Home Based Environmental Adherence Trial
  619. NCT00005524Mental Stress, Autonomic Function, and Heart Disease
  620. NCT00005525Sleep Apnea in Elderly Male Twins
  621. NCT00005526Genetic Basis of Abdominal Aortic Aneurysm
  622. NCT00005528Genetics of CVD Risk Factors in Samoans
  623. NCT00005529Self-Scored Cardiovascular Disease Risk Appraisal
  624. NCT00005530Diet, Insulin Resistance, and Cardiovascular Risk
  625. NCT00005531Genetic Epidemiology of Sarcoidosis
  626. NCT00005532Dietary Fat, Plasma Lipids, and Other CHD Risk Factors
  627. NCT00005533Hostility, Depression, Social Environment and CHD Risk
  628. NCT00005534Prevalence of Asymptomatic Ventricular Dysfunction
  629. NCT00005535Gene Mapping for Quantitative Traits
  630. NCT00005536Genetic Analysis of Human Hypertensive End Stage Renal Disease (H-ESRD)
  631. NCT00005537Genetics of Airway Responsiveness and Lung Function
  632. NCT00005538CHD Risk, Behavioral Stress and Reproductive Hormones
  633. NCT00005539Wisconsin Epidemiological Study of Cardiovascular Disease in Type 1 Diabetes
  634. NCT00005540Physical Fitness and Cardiovascular Mortality in Firefighters
  635. NCT00005541Hemochromatosis and Iron Overload Screening Study (HEIRS)
  636. NCT00005542Sarcoid Genetic Analysis (SAGA)
  637. NCT00005543Genetic Epidemiology of Venous Thromboembolism
  638. NCT00005544Community Based Study of Adult Onset Asthma
  639. NCT00005545Arterial Endothelial Function--An Epidemiologic Study
  640. NCT00005546Molecular Genetic Epidemiology of Three Cardiac Defects -SCOR in Pediatric Cardiovascular…
  641. NCT00005547Infection and Cardiovascular Disease
  642. NCT00005548Green Tea Consumption and Coronary Heart Disease
  643. NCT00005549Isocyanate Antigens and T Cells That Cause Asthma
  644. NCT00005550Endotoxin and Bronchial Inflammation in Asthma
  645. NCT00005551Sleep Apnea in a Non-Clinical Population
  646. NCT00005552Isocyanate Dermal Exposures in Autobody Shops
  647. NCT00005553Prospective Assessment After Pediatric Cardiac Ablation (PAPCA)
  648. NCT00005554Biobehavioral Predictors of Coronary Angioplasty Outcome
  649. NCT00005555Dose Response to Exercise and Cardiovascular Health
  650. NCT00005556Retention of Bone Marrow Donors in a National Registry
  651. NCT00005557Epidemiology of Sleep-Disordered Breathing in Adults
  652. NCT00005559Statistical Basis for Hemochromatosis Screening
  653. NCT00005560Prevalence and Correlates of Childhood Sleep Apnea
  654. NCT00005562Coronary Artery Calcium, Exercise Tests, and CHD Outcome
  655. NCT00005563Multicenter Asthma Research Collaboration
  656. NCT00005564Impact of Adult Asthma
  657. NCT00005565Mechanisms of Low Levels of Apolipoprotein B
  658. NCT00005566Cognitive Aspects of Adolescent Suicide
  659. NCT00005567Parental Knowledge and Beliefs About Infant Sleep Position
  660. NCT00005569Effects of Topical SLPI on Skin Wounds
  661. NCT00005570An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the…
  662. NCT00005571Safety and Effectiveness of h5G1.1-mAb for Dermatomyositis
  663. NCT00005572A Comparison of HIV-Infected Patients With and Without Opportunistic (AIDS-Related)…
  664. NCT00005574Gentamicin Treatment of Muscular Dystrophy
  665. NCT00005575Treatment of Non-Cardiac Chest Pain With Imipramine or Cognitive-Behavioral Therapy
  666. NCT00005576Monoclonal Antibody Therapy With Sargramostim and Interleukin-2 in Treating Children With…
  667. NCT00005577Gemcitabine in Treating Children With Refractory Solid Tumors
  668. NCT00005578Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's…
  669. NCT00005579Dolastatin 10 in Treating Patients With Indolent Lymphoma, Waldenstrom's…
  670. NCT00005580Bryostatin + Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia or…
  671. NCT00005581Combination Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer
  672. NCT00005583Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk…
  673. NCT00005584Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With…
  674. NCT00005585Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
  675. NCT00005586Leucovorin and Fluorouracil Compared With Observation in Treating Patients With Colorectal…
  676. NCT00005587Radiation Therapy After Surgery in Treating Women With Early Stage Breast Cancer
  677. NCT00005588Radiation Therapy After Surgery in Treating Women With Early Stage Breast Cancer
  678. NCT00005589Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without…
  679. NCT00005590Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid…
  680. NCT00005591Cetuximab Plus Gemcitabine in Treating Patients With Locally Advanced, Metastatic, or…
  681. NCT00005592Radioimmunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
  682. NCT00005593Fludarabine, Carboplatin, and Topotecan in Treating Patients With Relapsed/Refractory…
  683. NCT00005594ISIS 2503 in Treating Patients With Advanced Cancer of the Pancreas
  684. NCT00005595Arsenic Trioxide in Treating Patients With Relapsed or Refractory Hodgkin's Disease
  685. NCT00005596Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic…
  686. NCT00005597S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal…
  687. NCT00005598Azacitidine Plus Amifostine in Treating Patients With Myelodysplastic Syndrome
  688. NCT00005599Bryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic…
  689. NCT00005600Axillary Drainage Following Lymph Node Dissection in Women With Stage I or Stage II Breast…
  690. NCT00005601Combination Chemotherapy Plus Rituximab in Treating Patients With Relapsed Non-Hodgkin's…
  691. NCT00005602Radiation Therapy Plus Carboplatin and Lobradimil in Treating Children With Newly…
  692. NCT00005603Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
  693. NCT00005604Interleukin-12 Plus Interleukin-2 in Treating Patients With Advanced Solid Tumors
  694. NCT00005605Tamoxifen to Prevent Bone Loss and Heart Disease in Premenopausal Women Receiving…
  695. NCT00005606Peripheral Blood Lymphocyte Therapy to Prevent Lymphoproliferative Disorders Caused by…
  696. NCT00005607Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the…
  697. NCT00005608Fluorouracil-Uracil and Leucovorin in Treating Women With Metastatic Breast Cancer
  698. NCT00005609Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia
  699. NCT00005610Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the…
  700. NCT00005611BMS-188797 in Treating Patients With Advanced Solid Tumors That Have Not Responded to…
  701. NCT00005612Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating…
  702. NCT00005613Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or…
  703. NCT00005614Management of Metastatic Breast Cancer in Frail Patients
  704. NCT00005615Post-Operative Adjuvant Radiotherapy With Concurrent Interferon-Alfa
  705. NCT00005616Monoclonal Antibody Therapy in Treating Patients With Colorectal Cancer
  706. NCT00005617Vaccine Therapy in Treating Patients With Stage IV or Relapsed Malignant Melanoma
  707. NCT00005618Arsenic Trioxide in Treating Patients With Relapsed or Refractory Chronic Myelogenous…
  708. NCT00005619Analysis of Blood and Bone Marrow to Detect Residual Disease in Patients With Previously…
  709. NCT00005622Donor Bone Marrow Transplant in Treating Patients With Leukemia, Lymphoma, or Nonmalignant…
  710. NCT00005623Cyproterone Acetate in Treating Hot Flashes Following Surgical or Chemical Castration for…
  711. NCT00005624CI-994 in Treating Patients With Advanced Myeloma
  712. NCT00005625Ecteinascidin 743 in Treating Patients With Previously Treated Metastatic Osteosarcoma
  713. NCT00005626Phase II Trial With Correlative Laboratory Studies of Single Agent Irinotecan (Camptosar…
  714. NCT00005627Estramustine, Docetaxel, and Carboplatin in Treating Patients With Prostate Cancer That…
  715. NCT00005628Vaccine Therapy in Treating Patients With Recurrent Soft Tissue Sarcoma
  716. NCT00005629Vaccine Therapy in Treating Patients With Liver Cancer
  717. NCT00005630Vaccine Therapy and Sargramostim in Treating Patients With Non-small Cell Lung Cancer
  718. NCT00005631Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory…
  719. NCT00005632Vaccine Therapy Plus QS21 in Treating Patients With Prostate Cancer
  720. NCT00005633Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma
  721. NCT00005634Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have…
  722. NCT00005635Trastuzumab Plus Paclitaxel in Treating Women With Metastatic Breast Cancer That…
  723. NCT00005636Cisplatin With or Without Pemetrexed Disodium in Treating Patients With Malignant…
  724. NCT00005637Combination Chemotherapy Following Radiation Therapy in Treating Patients With Malignant…
  725. NCT00005638Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal…
  726. NCT00005639Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid…
  727. NCT00005640Lymphatic Mapping and Sentinel Lymph Node Biopsy in the Treatment of Colorectal Cancer
  728. NCT00005641Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow…
  729. NCT00005642SU5416 in Treating Patients With Advanced Solid Tumors
  730. NCT00005643Chemotherapy in Treating Patients With Sarcoma of the Uterus
  731. NCT00005644Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and…
  732. NCT00005645ILX-295501 in Treating Patients With Stage III or Stage IV Ovarian Cancer That Has Not…
  733. NCT00005646Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer
  734. NCT00005647SU5416 and Paclitaxel in Treating Patients With Recurrent, Locally Advanced or Metastatic…
  735. NCT00005648Gemcitabine With or Without Tipifarnib (R115777) in Treating Patients With Advanced…
  736. NCT00005649Paclitaxel and Capecitabine in Treating Women With Metastatic Breast Cancer
  737. NCT00005650Genetic Study of Patients With Primary Ciliary Dyskinesia
  738. NCT00005652Phase II Study of Rituximab in Patients With Immune Thrombocytopenic Purpura
  739. NCT00005654Randomized Study of the Effect of Decreased Hyperinsulinemia on the Ovulatory Response to…
  740. NCT00005655Combination Therapy of Interleukin-12 and Interleukin-2 to Treat Advanced Cancer
  741. NCT00005657Genetics of Hepatitis C Virus Infection
  742. NCT00005658Glycine to Treat Psychotic Disorders in Children
  743. NCT00005660The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of…
  744. NCT00005663A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected…
  745. NCT00005664Evaluation of Patients With Endocrine-Related Conditions
  746. NCT00005665Ingested Interferon Alpha: Prolongation or Permanence of the "Honeymoon" Phase in Newly…
  747. NCT00005666Utility of Anatometabolic Imaging for Radiation Treatment Planning for Lung Cancer
  748. NCT00005667Vancomycin Resistant Enterococci in Patients Awaiting Liver Transplantation at the…
  749. NCT00005668A Multicenter, Prospective, Randomized, Double-Blind Clinical Trial Comparing Itraconazole…
  750. NCT00005669Metformin to Treat Obesity in Children With Insulin Resistance
  751. NCT00005671Quality of Life in Patients With Chronic Ischemic Heart Disease
  752. NCT00005673Safety and Anti-HIV Activity of Capravirine Alone and in Combination With Other Anti-HIV…
  753. NCT00005674Clinical Trial of Creatine in Amyotrophic Lateral Sclerosis [ALS]
  754. NCT00005675Oral Type I Collagen for Relieving Scleroderma
  755. NCT00005676High Density Lipoprotein Subspecies and Coronary Disease
  756. NCT00005677Percutaneous Transluminal Coronary Angioplasty (PTCA) Registries I, II, and III and the…
  757. NCT00005678Multinational Monitoring of Trends and Determinants in Cardiovascular Disease (MONICA)
  758. NCT00005679Pathobiological Determinants of Atherosclerosis in Youth (PDAY)
  759. NCT00005680Whitehall II - Social and Occupational Influences On Health and Illness
  760. NCT00005681Vascular Basis for the Treatment of Ischemia
  761. NCT00005682Aplastic Anemia Epidemiology: Incidence and Case-control
  762. NCT00005683Clinical Interventions in Respiratory Distress Syndrome and Neonatal Lung Injury - SCOR in…
  763. NCT00005684Oral Anticoagulant Therapy for Venous Thrombosis - SCOR in Thrombosis
  764. NCT00005685Blood Pressure Control--Racial and Psychosocial Influences
  765. NCT00005686Dietary Intervention Methods for Clinical Trials
  766. NCT00005687Recycling Attempters and Relapsers in Smoking Cessation
  767. NCT00005688Cardiac Arrhythmias and the Perception of Symptoms
  768. NCT00005689Trial of Smoking Cessation Programs in Black Churches
  769. NCT00005690Improving Outcomes and Quality of Life After CABG
  770. NCT00005691Psychosocial Risk Factors for Coronary Heart Disease in Swedish Women
  771. NCT00005692Inflammation Markers Over Time in Cardiovascular Disease
  772. NCT00005693Computer Assisted Instruction Weight Management for Low Literacy Populations
  773. NCT00005694Worksites, Occupational Nurses and Cholesterol Change
  774. NCT00005695Physical Training and Blood Pressure in High Risk Youths
  775. NCT00005696Early Atherosclerosis Change in Two Clinical Trials
  776. NCT00005697Intervention for Resistant Pregnant Smokers
  777. NCT00005698IN CONTROL--Hypertension Reduction in Inner City Seattle
  778. NCT00005699Improving Hypertension Control in the Inner City
  779. NCT00005700Fat Reduction Intervention Trial in African-Americans
  780. NCT00005701Acute Cardiac Ischemia in Women in the ACI/TIPI Trial
  781. NCT00005702Promoting Smoking Cessation in Hospital Patients
  782. NCT00005703Hemostasis in Sickle Cell Disease--Infancy to Adulthood
  783. NCT00005704Pharmacologic Intervention for Postcessation Weight Gain
  784. NCT00005705Adherence in the Childhood Asthma Management Program
  785. NCT00005706Urban African-American Community Hypertension Control
  786. NCT00005707Improving Hypertension Care for Inner City Minorities
  787. NCT00005708Improving Adherence to Interventions for Hypertension
  788. NCT00005709Lipoprotein Metabolism in Hypertensive African-Americans
  789. NCT00005710Recycling of Chronic Smokers to Sustained Abstinence
  790. NCT00005711Intervention for Hispanic Children With Asthma
  791. NCT00005712Self Management Education Asthma
  792. NCT00005713Childhood Asthma Program in NYC Health Department Clinics
  793. NCT00005714Development and Evaluation of Community Asthma Program
  794. NCT00005715Community Intervention for Minority Children With Asthma
  795. NCT00005716Asthma Partnership for Minority Children
  796. NCT00005717Medication Adherence in COPD--A Self-Regulation Study
  797. NCT00005718Evaluation of Cholesterol Education for At-Risk Children
  798. NCT00005719Sustaining Women's Smoking Cessation Postpartum
  799. NCT00005720Lay-Led Smoking Cessation Approach for Southeast Asian Men
  800. NCT00005721Retaining Donors and Increasing Donation Frequency
  801. NCT00005722Stroke Belt Initiative
  802. NCT00005723Worksite Issues in Organizational Health Promotion (Take Heart)
  803. NCT00005724CVD Nutrition Modules Tailored to Low Literacy Skills
  804. NCT00005725Low Literacy CVD Diet Education for Blacks
  805. NCT00005726Evaluation of Low Literacy CVD Nutrition Education
  806. NCT00005727CVD Nutrition Education
  807. NCT00005728Nutrition Education
  808. NCT00005729CVD Nutrition Education for Low Literacy ESL Students
  809. NCT00005730National Marrow Donor Program (NMDP)
  810. NCT00005731Develop and Implement Asthma Controlling Strategies
  811. NCT00005732Develop and Implement Asthma Controlling Strategies (1)
  812. NCT00005733Develop and Implement Asthma Controlling Strategies (2)
  813. NCT00005734Intervention to Improve Asthma Management/Prevention
  814. NCT00005735Controlling Asthma at School
  815. NCT00005736Interventions to Improve Asthma Management/Prevention at School
  816. NCT00005737Tuberculosis Prophylaxis in the Homeless--A Controlled Trial
  817. NCT00005738Promoting Adherence to TB Regimens in Latino Adolescents
  818. NCT00005739Behavioral Interventions for Control of TB
  819. NCT00005740TB Contact Investigation: Behavioral Intervention
  820. NCT00005741Indigenous Outreach Among Injection Drug Users to Treat and Control TB
  821. NCT00005742Behavioral Interventions for Control of Tuberculosis
  822. NCT00005743Exercise Adherence in a Behavioral Weight Loss Program
  823. NCT00005744Increased Physical Activity in African-American Women
  824. NCT00005745Consequences and Correlates of Weight Fluctuations
  825. NCT00005746Community Site Coronary Risk Control in Black Families
  826. NCT00005748Stress Reduction and Prevention of Hypertension in Blacks
  827. NCT00005749Project Andale--Increasing Exercise in Hispanic Women
  828. NCT00005750School and Family-Based Obesity Prevention for Children
  829. NCT00005751Endothelial Vasomotor Function in the Framingham Study
  830. NCT00005752Overweight Adults--Ethnic, SES and Behavioral Influences
  831. NCT00005753Pharmacological and Behavioral Treatment of Insomnia
  832. NCT00005754Coronary Artery Calcification in Type 1 Diabetes
  833. NCT00005755Community Based Study on Occupational Asthma
  834. NCT00005756Epidemiology of Coronary Calcification in the Elderly
  835. NCT00005757Racial Variation in ACE--Genetic and Physiologic Bases
  836. NCT00005758Effectiveness of Giving an HIV Vaccine (Remune) to HIV-Positive Patients Receiving an…
  837. NCT00005760Health Effects of Liposuction in Overweight Women With Elevated Insulin Levels, Impaired…
  838. NCT00005761Blood Factors and Diabetic Retinopathy
  839. NCT00005762Drug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease…
  840. NCT00005763INTERSALT: International Study of Sodium, Potassium, and Blood Pressure
  841. NCT00005764A Study of Increased Lactic Acid and Abnormal Fat Distribution in HIV-Positive Patients
  842. NCT00005765Behavioral Economics of Human Drug Self-Administration
  843. NCT00005766Clinical Trial of Creatine in Amyotrophic Lateral Sclerosis
  844. NCT00005767Dynamic Aspects of Amino Acid Metabolism
  845. NCT00005768Estrogen Modulation of Mood and Cognition Following Monoaminergic Depletion in…
  846. NCT00005769Hormone Replacement Therapy and Insulin Action: A Double-Blind, Parallel…
  847. NCT00005770Investigation of the Effect of Acupuncture Needling on Connective Tissue Using Ultrasound…
  848. NCT00005771The Use of Real Time Ultrasound Feedback in Teaching Abdominal Hollowing Exercises
  849. NCT00005772Whole-Body Cooling for Birth Asphyxia in Term Infants
  850. NCT00005773Early Inhaled Nitric Oxide for Respiratory Failure in Newborns
  851. NCT00005774Early Surfactant to Reduce Use of Mechanical Breathing in Low Birth Weight Infants
  852. NCT00005775Glutamine Supplementation to Prevent Death or Infection in Extremely Premature Infants
  853. NCT00005776Inhaled Nitric Oxide Study for Respiratory Failure in Newborns
  854. NCT00005777Minimal Breathing Support and Early Steroids to Prevent Chronic Lung Disease in Extremely…
  855. NCT00005778High-Dose Intravenous (IV) Cyclophosphamide Versus Monthly IV Cyclophosphamide
  856. NCT00005779Safety of the Candidate Vaccine C4-V3 Alone or With Interleukin-12 (IL-12) in HIV-Infected…
  857. NCT00005780Chemotherapy Plus Vaccination to Treat Mantle Cell Lymphoma
  858. NCT00005781Assessment of Digital Imaging as a Tool for Diagnosing Psoriasis, Hand Rashes and Unusual…
  859. NCT00005782Mobilization and Handling of Stem Cells for Transplant From Healthy Volunteers With Sickle…
  860. NCT00005783A Phase I/II Trial of Recombinant-Methionyl Human Stem Cell Factor (SCF) in Adult Patients…
  861. NCT00005784Evaluation and Treatment of Patients With Retinal Disease
  862. NCT00005785Stem Cell (Modified Bone Marrow) Transplantation in HIV-Infected Patients With Blood…
  863. NCT00005786Arsenic Trioxide in Treating Patients With Relapsed or Refractory Lymphoma or Leukemia
  864. NCT00005787Peripheral Stem Cell Transplantation to Prevent Neutropenia in Patients Receiving…
  865. NCT00005788Interleukin-2 in Treating Patients With Mycosis Fungoides or Sezary Syndrome
  866. NCT00005790Perfusion Magnetic Resonance Imaging in Measuring the Growth of Blood Vessels in Newly…
  867. NCT00005791Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid…
  868. NCT00005792Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients…
  869. NCT00005793A Phase I/II Study of Induction Chemotherapy With Daunorubicin, Cytarabine, Topotecan and…
  870. NCT00005794Perifosine in Treating Patients With Advanced Solid Tumors
  871. NCT00005795Arsenic Trioxide in Treating Patients With Acute Myeloid Leukemia
  872. NCT00005796Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors
  873. NCT00005797Bone Marrow Transplant in Treating Patients With Hematologic Cancers
  874. NCT00005798Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating…
  875. NCT00005799Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in…
  876. NCT00005800Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer
  877. NCT00005801Total-Body Irradiation Plus Stem Cell Transplantation And White Blood Cell Infusion in…
  878. NCT00005802Chemotherapy Followed by Donor White Blood Cells Plus Interleukin-2 in Treating Patients…
  879. NCT00005803Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating…
  880. NCT00005804Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
  881. NCT00005805St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone…
  882. NCT00005806Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer
  883. NCT00005807Treating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian Cancer
  884. NCT00005808Photodynamic Therapy Using Lutetium Texaphyrin in Treating Patients With Cervical…
  885. NCT00005809Computerized Tomographic Colonography Compared With Standard Diagnostic Procedures in…
  886. NCT00005810Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate…
  887. NCT00005811Topotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded…
  888. NCT00005812Temozolomide in Treating Patients With Leptomeningeal Metastases From a Solid Tumor or…
  889. NCT00005813Bispecific Antibody Plus White Blood Cells in Treating Patients With Recurrent or…
  890. NCT00005814Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Stage III…
  891. NCT00005815Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV Melanoma
  892. NCT00005816Vaccine Therapy in Treating Patients With Stage III or Stage IV Kidney Cancer
  893. NCT00005817Rebeccamycin Analogue in Treating Women With Stage IIIB or Stage IV Breast Cancer
  894. NCT00005818SU5416 and Irinotecan in Treating Patients With Advanced Colorectal Cancer
  895. NCT00005819Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
  896. NCT00005820Nitrocamptothecin in Treating Patients With Stage IV Prostate Cancer That Has Not…
  897. NCT00005821Sentinel Lymph Node Biopsy to Assess Axillary Lymph Nodes in Women With Stage I or Stage…
  898. NCT00005822SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory…
  899. NCT00005823Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute…
  900. NCT00005824Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With…
  901. NCT00005825Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell…
  902. NCT00005826Nitrocamptothecin in Treating Patients With Glioblastoma Multiforme
  903. NCT00005827Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate Cancer
  904. NCT00005828Green Tea Extract in Treating Patients With Metastatic Prostate Cancer That Has Not…
  905. NCT00005829Gemcitabine in Treating Patients With Recurrent Chronic Lymphocytic Leukemia
  906. NCT00005830Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or…
  907. NCT00005831Trastuzumab and Combination Chemotherapy in Treating Patients With Locally Recurrent or…
  908. NCT00005832S9924 R115777 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
  909. NCT00005833S9923 R115777 in Treating Patients With Advanced Colorectal Cancer
  910. NCT00005834S9922 Combination Chemo Plus Filgrastim With or Without Thalidomide in Refractory Multiple…
  911. NCT00005835N99-02: Melphalan and Buthionine Sulfoximine
  912. NCT00005836Oxaliplatin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or…
  913. NCT00005837Oxaliplatin in Treating Patients With Recurrent or Refractory Cervical Cancer
  914. NCT00005838Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating…
  915. NCT00005839Oxaliplatin Plus Capecitabine in Treating Patients With Metastatic or Recurrent Solid…
  916. NCT00005840Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or…
  917. NCT00005841Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma
  918. NCT00005842Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer
  919. NCT00005843R115777 in Treating Patients Who Have Metastatic Pancreatic Cancer
  920. NCT00005844Oxaliplatin in Treating Children With Advanced Solid Tumors
  921. NCT00005845Tipifarnib in Treating Patients With Myelodysplastic Syndromes
  922. NCT00005847Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic…
  923. NCT00005848R115777 in Treating Patients With Progressive, Metastatic Prostate Cancer That Has Not…
  924. NCT00005849Bryostatin 1 Plus Paclitaxel in Treating Patients With Stage IIIB, Stage IV, or Recurrent…
  925. NCT00005850Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent…
  926. NCT00005851Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed By Donor Peripheral…
  927. NCT00005852Bone Marrow Transplantation in Treating Patients With Severe Aplastic Anemia or Rejection…
  928. NCT00005853Biological Therapy in Treating Patients With Myelodysplastic Syndrome
  929. NCT00005854Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
  930. NCT00005855Efaproxiral Plus Carmustine in Treating Patients With Progressive or Recurrent Malignant…
  931. NCT00005856Oxaliplatin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
  932. NCT00005857Trastuzumab and Docetaxel in Treating Patients Who Have Metastatic Prostate Cancer That Is…
  933. NCT00005858LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung…
  934. NCT00005859Tipifarnib in Treating Patients With Recurrent or Progressive Malignant Glioma
  935. NCT00005860Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With…
  936. NCT00005861Liposomal Doxorubicin in Treating Patients With Advanced or Recurrent Endometrial Cancer
  937. NCT00005862SU5416 in Treating Patients With Advanced, Metastatic, or Recurrent Soft Tissue Sarcomas
  938. NCT00005863Combination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients…
  939. NCT00005864Chloroquinoxaline Sulfonamide in Treating Patients With Stage IV Colorectal Cancer
  940. NCT00005865Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
  941. NCT00005866S9920 Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body…
  942. NCT00005867Combination Chemotherapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
  943. NCT00005868Docetaxel and Cisplatin in Treating Patients With Untreated Stage IIIA Non-small Cell Lung…
  944. NCT00005869Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally…
  945. NCT00005870Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or…
  946. NCT00005871Nitrocamptothecin or Fluorouracil in Treating Patients With Recurrent or Refractory…
  947. NCT00005872Nitrocamptothecin in Treating Patients With Recurrent Non-small Cell Lung Cancer
  948. NCT00005873Nitrocamptothecin in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
  949. NCT00005874Nitrocamptothecin in Treating Patients With Soft Tissue Sarcomas
  950. NCT00005875Nitrocamptothecin in Treating Patients With Metastatic Melanoma
  951. NCT00005876Nitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer…
  952. NCT00005877Nitrocamptothecin in Treating Patients With Advanced or Recurrent Colorectal Cancer
  953. NCT00005878Celecoxib to Prevent Cancer in Patients With Barrett's Esophagus
  954. NCT00005879LY353381 in Preventing Breast Cancer in Women With Hyperplasia
  955. NCT00005880Budesonide in Treating Former and Current Smokers With Bronchial Dysplasia
  956. NCT00005881Quality of Life in Children Treated for Cancer
  957. NCT00005883Phenethyl Isothiocyanate in Preventing Lung Cancer in People Who Smoke
  958. NCT00005884Eflornithine to Prevent Skin Cancer in Patients With Previously Treated Early Stage Skin…
  959. NCT00005886Tamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast Cancer
  960. NCT00005887Radiation Therapy With or Without RSR13 in Treating Patients With Brain Metastases
  961. NCT00005888Study of the Relationship Between Feeding and Late Onset Sepsis and/or Necrotizing…
  962. NCT00005889Gluconeogenesis in Very Low Birth Weight Infants Who Are Receiving Nutrition By…
  963. NCT00005890Diagnostic Study of Adrenal Cortical Function in Children With Septic Shock
  964. NCT00005891Study of Allogeneic Bone Marrow Transplantation Following Cyclophosphamide and…
  965. NCT00005892Study of Allogeneic Bone Marrow Transplantation Following Cyclophosphamide and…
  966. NCT00005893Study of Allogeneic Bone Marrow Transplantation Using Matched, Related Donors in Patients…
  967. NCT00005896Phase I Pilot Study of CD34 Enriched, Fanconi's Anemia Complementation Group C Gene…
  968. NCT00005898Phase I/II Study of Total Body Irradiation, Cyclophosphamide, and Fludarabine Followed by…
  969. NCT00005900Study of Pulmonary Complications in Pediatric Patients With Storage Disorders Undergoing…
  970. NCT00005901Pamidronate to Treat Osteogenesis Imperfecta in Children
  971. NCT00005902Study of Brain and Spinal Cord Tumor Growth and Cyst Development in Patients With Von…
  972. NCT00005903Continuously Infused Recombinant-Methionyl Human Glial Cell Line-Derived Neurotrophic…
  973. NCT00005905Leptin to Treat Lipodystrophy
  974. NCT00005906Treatment With Octreotide in Patients With Lymphangioleiomyomatosis
  975. NCT00005907Comparison of Immune Response to Booster Vaccines in Blood Transplant Patients and Healthy…
  976. NCT00005908Primary Chemotherapy With Docetaxel-Capecitabine and Doxorubicin-Cyclophosphamide in…
  977. NCT00005909Study of Alkaptonuria
  978. NCT00005910Laparoscopy to Remove Pancreatic Tumors (Insulinomas)
  979. NCT00005911Magnetic Resonance Imaging to Study the Normal Eye
  980. NCT00005912Voriconazole to Prevent Systemic Fungal Infections in Children
  981. NCT00005914Genetics of Recurrent Early-Onset Depression
  982. NCT00005915A Comparison of Two Anti-HIV Treatment Plans
  983. NCT00005916PSA-Based Vaccine and Radiotherapy to Treat Localized Prostate Cancer
  984. NCT00005917Study of Chediak-Higashi Syndrome
  985. NCT00005918Effectiveness and Safety of Two Forms of Stavudine in HIV-Infected Patients
  986. NCT00005919Cause of Pigment Dispersion Syndrome
  987. NCT00005920Safety and Effectiveness of Giving L-743,872 to Patients With Thrush That Has Not Been…
  988. NCT00005921A Study of the Side Effects of L-743,872 in Men With Candidal Esophagitis
  989. NCT00005922Conditioning, the Placebo Effect, and Psoriasis
  990. NCT00005923The Effect of Estrogen and Progesterone Levels on Knee and Ankle Joint Laxity
  991. NCT00005924Effects of Long-Term Treatment With Valaciclovir (Valtrex) on Epstein-Barr Virus
  992. NCT00005925Brain Infusion of Muscimol to Treat Epilepsy
  993. NCT00005926Gemcitabine, Herceptin and Radiation to Treat Cancer of the Pancreas
  994. NCT00005927Study of Adrenal Gland Tumors
  995. NCT00005928Effects of Angiotensin-Converting Enzyme Inhibitor (Ramipril) Therapy on Blood Vessel…
  996. NCT00005931SU5416 in Patients With AIDS-Related Kaposi's Sarcoma Who Have Not Responded to Treatment
  997. NCT00005933Learning and Behavior Problems in Children With Chronic Granulomatous Disease and Related…
  998. NCT000059345-Azacytidine and Phenylbutyrate to Treat Severe Thalassemia
  999. NCT00005935Mycophenolate Mofetil and Cyclosporine to Treat Relapsing Aplastic Anemia
  1000. NCT00005936Collection of Liver Tissue for Virologic Studies

About this dataset

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov